NWAM LLC’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-870,796
Closed -$4.37M 628
2025
Q4
$4.37M Sell
870,796
-3,487
-0.4% -$21.4K 0.24% 100
2025
Q3
$8.18M Sell
874,283
-150,196
-15% -$1.52M 0.44% 46
2025
Q2
$11.6M Buy
1,024,479
+24,128
+2% +$206K 0.67% 26
2025
Q1
$8.58M Buy
1,000,351
+87,300
+10% +$824K 0.74% 19
2024
Q4
$9.81M Buy
913,051
+2,575
+0.3% +$19.8K 0.61% 36
2024
Q3
$5.17M Buy
+910,476
New +$5.25M 0.32% 75
2024
Q2
Sell
-836,730
Closed -$3.21M 180
2024
Q1
$3.21M Buy
836,730
+38,437
+5% +$216K 0.26% 86
2023
Q4
$7.43M Buy
798,293
+77,303
+11% +$532K 0.6% 30
2023
Q3
$4.72M Buy
720,990
+86,390
+14% +$688K 0.48% 43
2023
Q2
$5.16M Buy
634,600
+86,363
+16% +$740K 0.42% 51
2023
Q1
$4.7M Buy
+548,237
New +$5.47M 0.48% 47

Other funds holding AVXL